Preparation of chemically 'mutated' aprotinin homologues by semisynthesis. P1 substitutions change inhibitory specificity.
The semisynthesis of homologues of aprotinin (BPTI) is described. The P1 amino acid residue of these homologues was substituted by other amino acids using peptide synthetic methods. The reactive-site-modified inhibitor (with the Lys15-Ala16 peptide bond hydrolyzed) was used as starting material. All carboxyl groups of the modified inhibitor were esterified with methanol, then the Lys15 methyl ester group was hydrolyzed selectively. Afterwards, Lys15 itself was split off. A new amino acid residue was incorporated by using water-soluble carbodiimide combined with an acylation catalyst. tert-Butyl-ester-protected amino acids were used for reinsertion. The method was tested by re-insertion of Lys15 to reconstitute the original inhibitor. Thirteen BPTI homologues with coded (Lys, Glu, Gly, Ala, Val, Ile, Leu) or uncoded amino acids (Abu, Ape, aIle, Ahx, tLeu, Neo) in position 15 were synthesized and the specificity of the inhibitors investigated. Amongst these, [Val15]BPTI was shown to be an excellent inhibitor for human polymorphonuclear leukocyte elastase having a complex dissociation constant of 0.11 nM. This inhibitor showed no detectable affinity to bovine pancreatic trypsin.
Beckmann
J
J
Fakultät für Chemie, Universität Bielefeld, Federal Republic of Germany.
Mehlich
A
A
Schröder
W
W
Wenzel
H R
HR
Tschesche
H
H
D000595:Amino Acid Sequence; D007611:Aprotinin / Q000138:chemical synthesis*; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D005815:Genetic Code; D006801:Humans; D008407:Mast Cells / Q000378:metabolism; D009154:Mutation; D009504:Neutrophils / Q000201:enzymology; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors; D012689:Sequence Homology, Nucleic Acid; D013329:Structure-Activity Relationship
D007611:Aprotinin; D010196:Pancreatic Elastase